Review
Accepted on 31 Mar 2025
Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546717
Type at least 3 characters
7,540 articles
Original Research
Published on 31 Mar 2025
Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571332
- 492 views
Case Report
Published on 31 Mar 2025
Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566035
- 621 views
Original Research
Published on 31 Mar 2025
A weakly supervised deep learning framework for automated PD-L1 expression analysis in lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540087
- 699 views
Original Research
Published on 31 Mar 2025
The dual role of CXCL9/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1528103
- 962 views
Original Research
Published on 31 Mar 2025
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1493234
- 655 views
Original Research
Published on 31 Mar 2025
ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1531940
- 953 views
Original Research
Published on 31 Mar 2025
Nomogram based on CT imaging and clinical data to predict the efficacy of PD-1 inhibitors combined with chemotherapy in advanced gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1504387
- 642 views
Original Research
Published on 31 Mar 2025
Discovering biomarkers associated with infiltration of CD8+ T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1496640
- 725 views
Original Research
Published on 31 Mar 2025
Multidimensional transcriptomics based to illuminate the mechanisms of taurine metabolism in immune resistance of pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1567805
- 716 views
Original Research
Published on 31 Mar 2025
The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529029
- 770 views
Review
Published on 31 Mar 2025
Decoding the enigmatic role of T-cadherin in tumor angiogenesis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1564130
- 378 views
Review
Published on 31 Mar 2025
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1573522
- 646 views
Original Research
Published on 31 Mar 2025
Small extracellular vesicle miRNAs as biomarkers for predicting antitumor efficacy in lung adenocarcinoma treated with chemotherapy and checkpoint blockade
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1573043
- 780 views
Review
Accepted on 28 Mar 2025
Revealing the Mechanisms and Therapeutic Potential of Immune Checkpoint Proteins Across Diverse Protein Families
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1499663
Systematic Review
Accepted on 28 Mar 2025
Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565407
- 175 views